Note there is a change in status from Amber to Red for house dust mite immunotherapy (Acarizax®).
No new patient should be started on treatment in primary care.
People already being prescribed treatment in primary care should be able to continue to complete their course of treatment in primary care.
Following review by both primary care, secondary care and SPPG, the Shared Care Guideline (SCG) for hydroxychloroquine has been updated and is now published on the Interface Pharmacist Network Specialist Medicines Website (Link).
The updated SCG now includes an update in ophthalmic screening. This reflects The Royal College of Ophthalmologists updated guidelines.
Following a recent meeting of the Regional Group on Specialist Medicines, there have been a number of changes/additions to the Red Amber List. These changes are summarised in the letter available at the link below:
Update to the Red Amber list (March 2022)
To keep up to date with these changes, please add your email address to our mailing list on our homepage
The shared care guidelines for the following cardiology medicines have been updated and approved by the Regional Group on Specialist Medicines:
These guidelines have been updated to reflect the most up to date advice and can be accessed using the links above.
Following a recent meeting of the Regional Group on Specialist Medicines, there have been a number of changes/additions to the Red Amber List. These changes are summarised in the letter available at the link below:
Update to the Red Amber list (January 2022)
To keep up to date with these changes, please add your email address to our mailing list on our homepage
Following a recent meeting of the Regional Group on Specialist Medicines, there have been a number of changes/additions to the Red Amber List. These changes are summarised in the letter available at the link below:
Update to the Red Amber list (June 2021)
To keep up to date with these changes, please add your email address to our mailing list on our homepage
Following a recent meeting of the Regional Group on Specialist Medicines, there have been a number of changes/additions to the Red Amber List and a number of shared care guidelines and GP information sheets have been endorsed for use. These changes are summarised in the letter available at the link below:
Update to the Red Amber list (March 2021)
To keep up to date with these changes, please add your email address to our mailing list on our homepage
Following a recent meeting of the Regional Group on Specialist Medicines, there have been a number of additions to the Red Amber List. These changes are summarised in the letter available at the link below:
Update to the Red Amber list (December 2020)
To keep up to date with these changes, please add your email address to our mailing list on our homepage
Following two recent meetings of the Regional Group on Specialist Medicines, there have been a number of additions to the Red Amber List. These changes are summarised in the letter available at the link below:
Update to the Red Amber list (June 2020)
To keep up to date with these changes, please add your email address to our mailing list on our homepage
Following a recent meeting of the Regional Group on Specialist Medicines, there have been a number of additions to the Red Amber List. These changes are summarised in the letter available at the link below:
Update to the Red Amber list (December 2019)
To keep up to date with these changes, please add your email address to our mailing list on our homepage